SCHEMBL7790975

SCHEMBL7790975

COc1cc2nc(N)nc(-c3cccc(O)c3O)c2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.51
EGFR P00533 1/20 0.46
DHFR P00374 2/20 0.44
RET P07949 2/20 0.44
KIF5B P33176 1/20 0.44
KDR P35968 1/20 0.44
WHR1 P49842 1/20 0.42
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585771 0.90 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1MAPT
SCHEMBL7799233 0.80 ADORA2A (0.62) ADORA2AEGFRDHFRWHR1MAPT
SCHEMBL7799239 0.80 ADORA2A (0.51) ADORA2AEGFRDHFRWHR1MAPT
SCHEMBL7799376 0.80 ADORA2A (0.51) ADORA2AEGFRDHFRWHR1MAPT
SCHEMBL7790971 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1KMT2A
SCHEMBL7800422 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1MAPT
SCHEMBL7791033 0.79 ADORA2A (0.61) ADORA2AEGFRDHFRWHR1MAPT
SCHEMBL7791023 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1KMT2A
SCHEMBL5793277 0.78 PDE4A (0.54) ADORA2AEGFRDHFRRETKIF5B
SCHEMBL7800398 0.78 ADORA2A (0.55) ADORA2ADHFRWHR1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed